BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Onat A, Aydın M, Can G, Köroğlu B, Karagöz A, Altay S. High adiponectin levels fail to protect against the risk of hypertension and, in women, against coronary disease: involvement in autoimmunity? World J Diabetes 2013; 4(5): 219-225 [PMID: 24147206 DOI: 10.4239/wjd.v4.i5.219]
URL: https://www.wjgnet.com/1948-9358/full/v4/i5/219.htm
Number Citing Articles
1
Ou Wu, Xi Lu, Jianhang Leng, Xingyu Zhang, Wei Liu, Fenfang Yang, Hu Zhang, Jiajia Li, Saber Khederzadeh, Xiaodong Liu, Chengda Yuan. Reevaluating Adiponectin’s impact on obesity hypertension: a Chinese case-control studyBMC Cardiovascular Disorders 2024; 24(1) doi: 10.1186/s12872-024-03865-4
2
E. Sklyarov, T. Maksymets. Risk Factors and Predictors of Ischemic Heart Disease Onset in FemalesLviv clinical bulletin 2013; 4(4): 52 doi: 10.25040/lkv2013.04.052
3
Jun Muratsu, Kei Kamide, Takashi Fujimoto, Yasushi Takeya, Ken Sugimoto, Yoshiaki Taniyama, Atsuyuki Morishima, Katsuhiko Sakaguchi, Yuji Matsuzawa, Hiromi Rakugi. The Combination of High Levels of Adiponectin and Insulin Resistance Are Affected by Aging in Non-Obese Old PeoplesFrontiers in Endocrinology 2022; 12 doi: 10.3389/fendo.2021.805244
4
Tatiana A. Brodskaya, Nina I. Repina, Vera A. Nevzorova, Natalia G. Plekhova, Valentin B. Shumatov. Aortic stiffness and content of adipokines in the serum in persons of European and South Asian ethnicTerapevticheskii arkhiv 2021; 93(4): 397 doi: 10.26442/00403660.2021.04.200679
5
Altan Onat, İbrahim Dönmez, Yusuf Karadeniz, Hakan Çakır, Ayşem Kaya. Type-2 diabetes and coronary heart disease: common physiopathology, viewed from autoimmunityExpert Review of Cardiovascular Therapy 2014; 12(6): 667 doi: 10.1586/14779072.2014.910114
6
Shishir Sharma, Laura A. Colangelo, Donald Lloyd-Jones, David R. Jacobs, Myron D. Gross, Samuel S. Gidding, Philip Greenland. Longitudinal associations between adiponectin and cardiac structure differ by hypertensive status: Coronary Artery Risk Development in Young AdultsCardiovascular Endocrinology 2016; 5(2): 57 doi: 10.1097/XCE.0000000000000080
7
Shokei Kim-Mitsuyama, Hirofumi Soejima, Osamu Yasuda, Koichi Node, Hideaki Jinnouchi, Eiichiro Yamamoto, Taiji Sekigami, Hisao Ogawa, Kunihiko Matsui. Total adiponectin is associated with incident cardiovascular and renal events in treated hypertensive patients: subanalysis of the ATTEMPT-CVD randomized trialScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-52977-x
8
Poghni A. Peri‐Okonny, Colby Ayers, Naim Maalouf, Sandeep R. Das, James A. de Lemos, Jarett D. Berry, Aslan T. Turer, Ian J. Neeland, Philipp E. Scherer, Wanpen Vongpatanasin. Adiponectin protects against incident hypertension independent of body fat distribution: observations from the Dallas Heart StudyDiabetes/Metabolism Research and Reviews 2017; 33(2) doi: 10.1002/dmrr.2840
9
Servet Altay, Altan Onat, Yusuf Karadeniz, Fatma Özpamuk-Karadeniz, Günay Can. Prediction by Low Plasma HbA1c of Mortality, Cardiac and Noncardiac Disease Risk: Modulation by Diabetic Status and SexJournal of Investigative Medicine 2015; 63(6): 821 doi: 10.1097/JIM.0000000000000216
10
Altan Onat, Evin Ademoglu, Yusuf Karadeniz, Gunay Can, Ahmet Okan Uzun, Barıs Simsek, Aysem Kaya. Population-based serum omentin-1 levels: paradoxical association with cardiometabolic disorders primarily in menBiomarkers in Medicine 2018; 12(2): 141 doi: 10.2217/bmm-2017-0197